ArticleHemaSphere2024

Efficacy and safety of bendamustine-containing bridging therapy in R/R LBCL patients receiving CD19 CAR T-cells.

Gloria Iacoboni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.